Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Maternal chewing during prenatal stress ameliorates stress-induced hypomyelination, synaptic alterations, and learning impairment in mouse offspring.
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
Orderly Steps in Progression of JC Virus to Virulence in the Brain.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.
Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
N-Truncated Aβ 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.
Conditional Deletion of the L-Type Calcium Channel Cav1.2 in Oligodendrocyte Progenitor Cells Affects Postnatal Myelination in Mice.
Effect of teriflunomide on QuantiFERON-TB Gold results.
Ingested (oral) rituximab inhibits EAE.
Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications.
S100A8/A9: From basic science to clinical application.
Pages
« first
‹ previous
…
725
726
727
728
729
730
731
732
733
…
next ›
last »